...
【24h】

The excimer laser: science fiction fantasy or practical tool?

机译:准分子激光:科幻幻想还是实用工具?

获取原文
获取原文并翻译 | 示例

摘要

Nearly 20 years ago, in vitro experiments left no doubt about the fact that laser light can ablate atherosclerotic plaque. The initial enthusiastic results with the technology, particularly in coronary arteries, were followed by reports showing unacceptably high restenosis and complication rates. These poor results were due to the premature application of an underdeveloped technology, a lack of understanding of laser/tissue interaction, and the use of incorrect lasing techniques. Consequently, and without discrimination, all lasers were banned from the catheterization laboratories for nearly a decade. Technological enhancements of the excimer laser, combined with refined catheter lasing techniques, resulted in greater debulking of atherosclerotic material in long superficial femoral artery occlusions. These results triggered the application of the excimer laser technique as an atherectomy tool in more complex lesions below the knee. The multicenter Laser Atherectomy for Critical Ischemia study clearly demonstrated that the excimer laser technology resulted in limb salvage rates >90% in patients with critical limb ischemia (CLI). Furthermore, new clinical results indicate that the excimer laser is very effective in dissolving thrombotic obstructions, redirecting this technology to the coronary field. The results of the excimer laser in CLI validate the role of the cool laser in treating complex peripheral vascular disease. The results suggest a larger indication for this technology and support a more aggressive use of these interventional techniques in the treatment of this large patient cohort. However, all lasers are not equally effective in debulking atherosclerotic material. Only the athermic process associated with the excimer laser produces a safe and effective endovascular ablation of obstructive atherosclerotic and/or thrombotic material. The appropriate and safe utilization of the equipment and lasing techniques, combined with correct indications and patient selection, will contribute to the successful application of laser-assisted atherectomy in complex peripheral and coronary artery obstructive disease. Unfortunately, little consistent scientific data has been generated to convince the interventional community of the usefulness of excimer laser ablation.
机译:将近20年前,体外实验毫无疑问地证明了激光可以消融动脉粥样硬化斑块这一事实。该技术最初的热情成果,特别是在冠状动脉中,随后出现了报告,显示再狭窄和并发症发生率高得令人无法接受。这些较差的结果是由于未成熟技术的过早应用,对激光/组织相互作用的理解不足以及使用不正确的激光技术造成的。因此,近十年来,没有任何歧视,所有激光都被导管实验室禁止使用。受激准分子激光的技术增强与精巧的导管激光技术相结合,导致股浅长股动脉闭塞中动脉粥样硬化物质的减积更大。这些结果触发了准分子激光技术在膝盖以下较复杂的病变中作为斑块切除术的应用。一项针对重症缺血的多中心激光动脉粥样硬化切除术研究清楚表明,准分子激光技术可导致严重肢体缺血(CLI)患者的肢体抢救率> 90%。此外,新的临床结果表明,准分子激光在解决血栓阻塞方面非常有效,从而将该技术重定向到了冠状动脉领域。 CLI中准分子激光的结果验证了冷激光在治疗复杂的周围血管疾病中的作用。结果表明该技术具有更大的适应症,并支持更积极地使用这些介入技术来治疗这一庞大的患者群体。但是,所有激光在降低动脉粥样硬化材料方面均不一样有效。只有与准分子激光有关的动脉粥样硬化过程才能对阻塞性动脉粥样硬化和/或血栓形成物质进行安全有效的血管内消融。正确,安全地使用设备和激光技术,结合正确的适应症和患者选择,将有助于激光辅助斑块切除术在复杂的周围和冠状动脉阻塞性疾病中的成功应用。不幸的是,几乎没有产生一致的科学数据来使介入界相信准分子激光消融的有用性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号